[HTML][HTML] Serum amyloid A–a review
GH Sack Jr - Molecular medicine, 2018 - Springer
Serum amyloid A (SAA) proteins were isolated and named over 50 years ago. They are
small (104 amino acids) and have a striking relationship to the acute phase response with …
small (104 amino acids) and have a striking relationship to the acute phase response with …
Association between serum amyloid A levels and cancers: a systematic review and meta-analysis
J Zhou, J Sheng, Y Fan, X Zhu, Q Tao… - Postgraduate medical …, 2018 - academic.oup.com
Objective Increased serum amyloid A (SAA) levels have been investigated in various human
malignancies, but a consistent perspective has not been established to date. This study …
malignancies, but a consistent perspective has not been established to date. This study …
[HTML][HTML] Pretreatment serum amyloid a and c-reactive protein comparing with Epstein-Barr virus DNA as prognostic indicators in patients with nasopharyngeal …
QY Chen, QN Tang, LQ Tang… - … : Official Journal of …, 2018 - synapse.koreamed.org
Purpose The measuring Epstein-Barr virus (EBV) DNA is an important predictor of
nasopharyngeal carcinoma (NPC). This study evaluated the predictive value of pretreatment …
nasopharyngeal carcinoma (NPC). This study evaluated the predictive value of pretreatment …
[HTML][HTML] Matrix Metalloproteinase-9-Generated COOH-, but Not NH2-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to …
M Gouwy, M De Buck, S Abouelasrar Salama… - Frontiers in …, 2018 - frontiersin.org
Serum amyloid A1 (SAA1) is a prototypic acute phase protein, induced to extremely high
levels by physical insults, including inflammation and infection. Human SAA and its NH2 …
levels by physical insults, including inflammation and infection. Human SAA and its NH2 …
[HTML][HTML] Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
PJ Selby, RE Banks, W Gregory, J Hewison… - 2018 - europepmc.org
Background Protein biomarkers with associations with the activity and outcomes of diseases
are being identified by modern proteomic technologies. They may be simple, accessible …
are being identified by modern proteomic technologies. They may be simple, accessible …
[PDF][PDF] PROGRAMME GRANTS FOR APPLIED RESEARCH
PJ Selby, RE Banks, W Gregory, J Hewison… - 2018 - scholar.archive.org
Monitoring involves the scheduled, repeated use of a test or tests in an individual over time
to make decisions about the management of a disease or condition. It is a central activity in …
to make decisions about the management of a disease or condition. It is a central activity in …